TY - JOUR
T1 - Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation
T2 - Insights from serial intravascular ultrasound analysis in the TAXUS II study
AU - Aoki, Jiro
AU - Colombo, Antonio
AU - Dudek, Dariusz
AU - Banning, Adrian P.
AU - Drzewiecki, Janusz
AU - Zmudka, Krzysztof
AU - Schiele, Francois
AU - Russell, Mary E.
AU - Koglin, Joerg
AU - Serruys, Patrick W.
PY - 2005/12
Y1 - 2005/12
N2 - Background - The purpose of this study was to evaluate long-term vascular responses as long as 2 years after implantation of polymer-based, paclitaxel-eluting stents in contrast to uncoated stents. Methods and Results - TAXUS II is a randomized, double-blind trial comparing slow-release (SR) and moderate-release (MR) TAXUS stents with bare-metal control stents (BMSs). One hundred sixty-one event-free patients (SR, 43; MR, 41; and BMS, 77) underwent serial intravascular ultrasound (IVUS) analysis after the procedure and at 6 months and 2 years. At 2 years, neointimal responses continued to be significantly suppressed in the SR and MR groups when compared with the BMS group (BMS, 1.49±1.12 mm2; SR, 0.94±0.76 mm2 [P=0.004]; and MR, 1.06±0.90 mm2 [P=0.02]). Between 6 months and 2 years, the BMS group showed compaction of the neointima (Δ, -0.22± 1.05 mm2 [P=0.08]). In contrast, both the SR and MR groups exhibited an increase (Δ SR, 0.30±0.76 mm2 (P=0.01); MR, 0.41±0.94 mm2 [P=0.009]). Between 6 months and 2 years, the initial increase in plaque outside the stent regressed in the BMS and SR groups to levels comparable to those after the procedure, whereas expansive remodeling partially regressed in the MR group (Δ between after the procedure and 2 years BMS, -0.34±1.28 mm2 [P=0.05]; SR, -0.02±1.40 mm2 [P=0.93]; MR, 0.32±1.56 mm2 [P=0.27]). Conclusions - The 2-year follow-up demonstrates that neointimal suppression was dose independent and that this effect was still sustained at 2 years. However, the increase in area outside the stent seen at 6 months regressed to different extents in a dose-dependent manner at 2 years.
AB - Background - The purpose of this study was to evaluate long-term vascular responses as long as 2 years after implantation of polymer-based, paclitaxel-eluting stents in contrast to uncoated stents. Methods and Results - TAXUS II is a randomized, double-blind trial comparing slow-release (SR) and moderate-release (MR) TAXUS stents with bare-metal control stents (BMSs). One hundred sixty-one event-free patients (SR, 43; MR, 41; and BMS, 77) underwent serial intravascular ultrasound (IVUS) analysis after the procedure and at 6 months and 2 years. At 2 years, neointimal responses continued to be significantly suppressed in the SR and MR groups when compared with the BMS group (BMS, 1.49±1.12 mm2; SR, 0.94±0.76 mm2 [P=0.004]; and MR, 1.06±0.90 mm2 [P=0.02]). Between 6 months and 2 years, the BMS group showed compaction of the neointima (Δ, -0.22± 1.05 mm2 [P=0.08]). In contrast, both the SR and MR groups exhibited an increase (Δ SR, 0.30±0.76 mm2 (P=0.01); MR, 0.41±0.94 mm2 [P=0.009]). Between 6 months and 2 years, the initial increase in plaque outside the stent regressed in the BMS and SR groups to levels comparable to those after the procedure, whereas expansive remodeling partially regressed in the MR group (Δ between after the procedure and 2 years BMS, -0.34±1.28 mm2 [P=0.05]; SR, -0.02±1.40 mm2 [P=0.93]; MR, 0.32±1.56 mm2 [P=0.27]). Conclusions - The 2-year follow-up demonstrates that neointimal suppression was dose independent and that this effect was still sustained at 2 years. However, the increase in area outside the stent seen at 6 months regressed to different extents in a dose-dependent manner at 2 years.
KW - Remodeling
KW - Restenosis
KW - Stents
UR - http://www.scopus.com/inward/record.url?scp=33644877576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644877576&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.105.558601
DO - 10.1161/CIRCULATIONAHA.105.558601
M3 - Article
C2 - 16344384
AN - SCOPUS:33644877576
VL - 112
SP - 3876
EP - 3883
JO - Circulation
JF - Circulation
SN - 0009-7322
IS - 25
ER -